| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $22.67B | $18.68B | $11.81B |
| YoY Revenue Growth % | +21.3% | +58.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $8.36B | $3.95B | -$2.94B |
| Operating Margin % | 36.9% | 21.1% | -24.9% |
| Net Income (GAAP) | $7.08B | $3.35B | -$2.49B |
| EBITDA (Normalized) | $9.18B | $4.62B | -$2.52B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $10.33B | $6.36B | $2.76B |
| Capital Expenditures (CapEx) | $1.02B | $840.7M | $531.5M |
| Free Cash Flow (FCF) | $9.31B | $5.52B | $2.23B |
| FCF Margin % | 41.1% | 29.6% | 18.9% |
| Return on Invested Capital (ROIC %) | 21.1% | 9.2% | -6.0% |
| Cash & Short-Term Equivalents | $7.65B | $3.62B | — |
| Total Debt (Short + Long Term) | $5.12B | $7.55B | $14.95B |
| Total Stockholders' Equity | $33.87B | $29.93B | $30.67B |